Connecticut Innovations
“Veradermics went public earlier this year and has seen its stock price surge more than 550% for a $4.6 billion market cap. CI wrote the first $100,000 check.”
“Halda Therapeutics sold at the end of 2025 for $3.05 billion; CI was first check.”
“Quantum Circuits recently sold for $550 million; CI early investor.”
“CI now runs more like a traditional venture capital firm. Its comp structure has become competitive with the private sector, invests using standard NVCA documents, and has a portfolio ops team.”
“If a company ultimately doesn't grow in Connecticut — for example, it hires someone here and later eliminates that position — that doesn't trigger penalties or clawbacks. It simply makes it less likely we'll participate in future financing rounds.”
AI-extracted from podcast / newsletter / paper summaries. May contain errors.